HILPDA Antikörper (AA 21-63)
Kurzübersicht für HILPDA Antikörper (AA 21-63) (ABIN2175788)
Target
Alle HILPDA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 21-63
-
Homologie
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human HIG2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease." in: Journal of the American Heart Association, Vol. 6, Issue 12, (2018) (PubMed).
-
: "Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease." in: Journal of the American Heart Association, Vol. 6, Issue 12, (2018) (PubMed).
-
- HILPDA (Hypoxia Inducible Lipid Droplet-Associated (HILPDA))
-
Andere Bezeichnung
- HIG2
-
Hintergrund
-
Synonyms: C7orf68, chromosome 7 open reading frame 68, HIG 2, HIG2, HLPDA_HUMAN, Hypoxia-inducible gene 2 protein, Hypoxia-inducible lipid droplet-associated protein, Hypoxia-inducible protein 2.
Background: HIG2
Target
-